The prevailing assumption is that executives only need high-level briefings, not practical AI training. That's wrong.

Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...

The California governor painted the president as a threat to American competitiveness by letting China dominate the renewable ...

Merck’s enlicitide decanoate significantly reduced LDL-C in adults with heterozygous familial hypercholesterolemia in phase 3 CORALreef HeFH trial: Rahway, New Jersey Tuesday, N ...

Rezdiffra® treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk ...

If someone calls you claiming to be from Eversource, National Grid, or the like, beware. If they ask you to buy gift cards, ...

Support local journalism in New Hampshire during NewsMatch. Every dollar given will be matched, helping to fund nonprofit news reporting.

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the presentation of safety and early ...

Maine described its HIV outbreak as a significant health concern, but the shutdown has kept a CDC team from coming to the state's aid.

Friends and family visiting Houston during the holiday season will find art openings that appeal to every taste. Classic art ...

Richard Demaret Hausman died in his home on Longboat Key. He is survived by his wife, Edna, his daughter Elizabeth Lycke, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 CORALreef HeFH trial demonstrating that treatment ...